AIDS TREATMENT NEWS Issue #363, March 30, 2001
John S. James
Therapeutic drug monitoring (TDM) means measuring the level of a drug actually found in the blood (or inside certain blood cells), in order to adjust the drug dose up or down, either to make sure there is enough to inhibit HIV or to avoid side effects. The reason for measuring drug levels is that people are different, both in how well they absorb drugs from the stomach or intestines, and in how rapidly the body destroys or eliminates the drugs. For various reasons, there is most interest today in measuring blood levels of protease inhibitors.
For years there has been reluctance to measure HIV drug levels in routine patient care, because the current one- size-fits-all dosing is more convenient. Companies are racing to make their medicines easier to take (preferably a single pill once a day), and adjustable dosing would probably require more pills and/or increase the chances of error. Companies have incentive to sell their existing products -- not to bring attention to their variable blood levels or other complications.
TDM is not yet part of standard HIV care, but increasingly new information suggests that it may become important for helping antiretrovirals work better. In the future, it is likely that shortly after one has started taking a protease inhibitor (and perhaps other antiretrovirals as well), the blood level will be tested in order to adjust the dose if necessary.
Recently the Medscape HIV/AIDS Web site (http://hiv.medscape.com) added a page of links to recent articles, conference summaries, news reports, and other information about therapeutic drug monitoring in HIV treatment. This page will be updated as new information becomes available. Currently the link is under "Resource Centers" on the home page.
Note: You need to register in order to read the articles on the Medscape site, but registration is a one-time process and is free. You will need to make up a user name and a password, and write them down for when you use the site again; you will also be asked to complete a short survey. This site has much useful information and is worth the trouble of registering.
010330
ATN36303
Copyright © 2001 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content.